Ke, Xiaobo
You, Kwontae
Pichaud, Matthieu
Haiser, Henry J.
Graham, Daniel B.
Vlamakis, Hera
Porter, Jeffrey A.
Xavier, Ramnik J. https://orcid.org/0000-0002-5630-5167
Funding for this research was provided by:
Crohn's and Colitis Foundation of America (563579)
National Institutes of Health (P30 DK043351)
Center for Microbiome Informatics and Therapeutics (6932308)
Article History
Received: 7 August 2020
Accepted: 10 September 2021
First Online: 15 October 2021
Declarations
:
: Not applicable.
: R.J.X. is a consultant to Novartis and co-founder of Celsius Therapeutics and Jnana Therapeutics.